Sg Americas Securities, LLC Vaxart, Inc. Transaction History

Sg Americas Securities, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$0.6 - $1.41 $19,468 - $45,750	-32,447 Reduced 68.31%	15,055 $11,000
Q1 2023 Apr 28, 2023	SELL	$0.71 - $1.25 $687 - $1,210	-968 Reduced 2.0%	47,502 $36,000
Q4 2022 Feb 02, 2023	SELL	$0.75 - $2.24 $8,995 - $26,866	-11,994 Reduced 19.84%	48,470 $47,000
Q3 2022 Oct 31, 2022	SELL	$2.09 - $4.5 $198,612 - $427,635	-95,030 Reduced 61.11%	60,464 $132,000
Q2 2022 Jul 29, 2022	BUY	$2.7 - $5.28 $419,833 - $821,008	155,494 New	155,494 $544,000
Q1 2022 Apr 29, 2022	SELL	$4.29 - $6.64 $92,599 - $143,324	-21,585 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$5.77 - $7.96 $152,570 - $210,478	-26,442 Reduced 55.06%	21,585 $135,000
Q3 2021 Nov 01, 2021	BUY	$6.67 - $9.8 $320,340 - $470,664	48,027 New	48,027 $382,000
Q2 2021 Aug 12, 2021	SELL	$5.06 - $10.78 $62,470 - $133,089	-12,346 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$5.64 - $23.33 $18,674 - $77,245	-3,311 Reduced 21.15%	12,346 $75,000
Q4 2020 Feb 04, 2021	BUY	$3.5 - $7.98 $54,799 - $124,942	15,657 New	15,657 $89,000
Q3 2020 Nov 09, 2020	SELL	$4.78 - $16.97 $115,671 - $410,657	-24,199 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$1.68 - $8.85 $40,654 - $214,161	24,199 New	24,199 $214,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.